TGA testing finds unapproved peptides do not contain what their labels claim
Therapeutic Goods Administration (TGA) laboratory testing has found that tested Synedica peptide products did not contain what their labels claimed. Some tested products contained…
MH
By Maren Holt · Senior Reporter, GLP-1
Nov 4 18:40 ETSource: Therapeutic Goods Administration (TGA)
From the source
Read at tga.gov.auTGA testing finds unapproved peptides do not contain what their labels claim
Therapeutic Goods Administration (TGA) laboratory testing has found that tested Synedica peptide products did not contain what their labels claimed. Some tested products contained no detectable TB-500, despite being labelled as containing TB-500, while tested Synedica Retatrutide 10 mg products contained less retatrutide than stated on the label, with significant variation between samples.
